Siemens Healthineers AG (WBO:SHL) ROE % Adjusted to Book Value : 4.08% (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Siemens Healthineers AG ROE % Adjusted to Book Value?

Siemens Healthineers AG's ROE % for the quarter that ended in Sep. 2024 was 13.53%. Siemens Healthineers AG's PB Ratio for the quarter that ended in Sep. 2024 was 3.32. Siemens Healthineers AG's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 4.08%.

Siemens Healthineers AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Siemens Healthineers AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Siemens Healthineers AG ROE % Adjusted to Book Value Chart

Siemens Healthineers AG Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.83

3.11

4.49

2.66

3.23

Siemens Healthineers AG Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															4.07	2.90	2.74	3.08	4.08

Competitive Comparison of Siemens Healthineers AG's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Siemens Healthineers AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Siemens Healthineers AG's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Siemens Healthineers AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Siemens Healthineers AG's ROE % Adjusted to Book Value falls into.

Siemens Healthineers AG ROE % Adjusted to Book Value Calculation

Siemens Healthineers AG's ROE % Adjusted to Book Value for the fiscal year that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.71%	/	3.32
	=	3.23%

Siemens Healthineers AG's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	13.53%	/	3.32
	=	4.08%

Siemens Healthineers AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Siemens Healthineers AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Siemens Healthineers AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Siemens Healthineers AG (WBO:SHL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

SEMHF:USA SMMNY:USA 1SHL:Italy SHLd:UK 0PMJ:UK SHL:Germany

Address

Siemensstr. 3, Forchheim, BY, DEU, 91301

Website

https://www.siemens-healthineers.com

Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (55% of sales in fiscal 2023) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (16% of sales) offers radiotherapy and other oncology solutions. The portfolio of the diagnostics segment (21%) includes in vitro diagnostics products offered to providers and point-of-care diagnostics. The advanced therapies segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. North America represents 41% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific including China the remainder.

Siemens Healthineers AG Headlines

No Headlines